Agenus Inc. (AGEN)
USD 1.7
(-7.61%)
USD 1.7
(-7.61%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 156.31 Million USD | 59.47% |
| 2022 | 98.02 Million USD | -66.85% |
| 2021 | 295.66 Million USD | 235.34% |
| 2020 | 88.17 Million USD | -41.24% |
| 2019 | 150.04 Million USD | 307.92% |
| 2018 | 36.78 Million USD | -14.21% |
| 2017 | 42.87 Million USD | 89.95% |
| 2016 | 22.57 Million USD | -9.04% |
| 2015 | 24.81 Million USD | 255.7% |
| 2014 | 6.97 Million USD | 129.13% |
| 2013 | 3.04 Million USD | -80.92% |
| 2012 | 15.96 Million USD | 479.18% |
| 2011 | 2.75 Million USD | -17.97% |
| 2010 | 3.35 Million USD | 0.77% |
| 2009 | 3.33 Million USD | 25.76% |
| 2008 | 2.65 Million USD | -52.25% |
| 2007 | 5.55 Million USD | 702.2% |
| 2006 | 692.13 Thousand USD | 9.87% |
| 2005 | 629.97 Thousand USD | -10.9% |
| 2004 | 707.07 Thousand USD | -84.11% |
| 2003 | 4.44 Million USD | 30.43% |
| 2002 | 3.41 Million USD | -25.1% |
| 2001 | 4.55 Million USD | 929.08% |
| 2000 | 442.62 Thousand USD | 342.63% |
| 1999 | 100 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 28 Million USD | -66.58% |
| 2024 Q2 | 23.5 Million USD | -16.05% |
| 2023 FY | 156.31 Million USD | 59.47% |
| 2023 Q3 | 24.31 Million USD | -3.88% |
| 2023 Q2 | 25.29 Million USD | 10.45% |
| 2023 Q4 | 83.8 Million USD | 244.66% |
| 2023 Q1 | 22.9 Million USD | -19.32% |
| 2022 Q3 | 22.77 Million USD | 8.82% |
| 2022 Q1 | 25.94 Million USD | 28.03% |
| 2022 FY | 98.02 Million USD | -66.85% |
| 2022 Q4 | 28.38 Million USD | 24.65% |
| 2022 Q2 | 20.92 Million USD | -19.33% |
| 2021 FY | 295.66 Million USD | 235.34% |
| 2021 Q2 | 10.73 Million USD | -8.44% |
| 2021 Q1 | 11.71 Million USD | -62.52% |
| 2021 Q4 | 20.26 Million USD | -91.99% |
| 2021 Q3 | 252.95 Million USD | 2257.45% |
| 2020 Q4 | 31.26 Million USD | 110.79% |
| 2020 Q2 | 26.94 Million USD | 78.11% |
| 2020 Q1 | 15.12 Million USD | -56.15% |
| 2020 FY | 88.17 Million USD | -41.24% |
| 2020 Q3 | 14.83 Million USD | -44.95% |
| 2019 Q3 | 19.94 Million USD | 26.89% |
| 2019 Q4 | 34.5 Million USD | 73.02% |
| 2019 Q1 | 79.89 Million USD | 1138.53% |
| 2019 Q2 | 15.71 Million USD | -80.33% |
| 2019 FY | 150.04 Million USD | 307.92% |
| 2018 Q3 | 12.8 Million USD | -19.45% |
| 2018 FY | 36.78 Million USD | -14.21% |
| 2018 Q1 | 1.63 Million USD | -80.42% |
| 2018 Q2 | 15.89 Million USD | 871.53% |
| 2018 Q4 | 6.45 Million USD | -49.62% |
| 2017 Q3 | 3.35 Million USD | -20.15% |
| 2017 FY | 42.87 Million USD | 89.95% |
| 2017 Q1 | 26.95 Million USD | 383.43% |
| 2017 Q2 | 4.2 Million USD | -84.39% |
| 2017 Q4 | 8.35 Million USD | 148.68% |
| 2016 Q3 | 4.44 Million USD | -32.55% |
| 2016 Q2 | 6.59 Million USD | 10.62% |
| 2016 FY | 22.57 Million USD | -9.04% |
| 2016 Q4 | 5.57 Million USD | 25.42% |
| 2016 Q1 | 5.95 Million USD | -21.99% |
| 2015 FY | 24.81 Million USD | 255.7% |
| 2015 Q2 | 6.37 Million USD | 61.32% |
| 2015 Q1 | 3.95 Million USD | 144.16% |
| 2015 Q4 | 7.63 Million USD | 11.55% |
| 2015 Q3 | 6.84 Million USD | 7.39% |
| 2014 FY | 6.97 Million USD | 129.13% |
| 2014 Q4 | 1.61 Million USD | 3.56% |
| 2014 Q2 | 3.07 Million USD | 326.35% |
| 2014 Q3 | 1.56 Million USD | -49.14% |
| 2014 Q1 | 721 Thousand USD | 83.46% |
| 2013 FY | 3.04 Million USD | -80.92% |
| 2013 Q4 | 393 Thousand USD | -46.6% |
| 2013 Q1 | 1.1 Million USD | 1.74% |
| 2013 Q3 | 736 Thousand USD | -8.8% |
| 2013 Q2 | 807 Thousand USD | -27.23% |
| 2012 Q1 | 13.37 Million USD | 1977.57% |
| 2012 Q4 | 1.09 Million USD | 25.43% |
| 2012 FY | 15.96 Million USD | 479.18% |
| 2012 Q2 | 627 Thousand USD | -95.31% |
| 2012 Q3 | 869 Thousand USD | 38.6% |
| 2011 Q1 | 671.88 Thousand USD | -32.38% |
| 2011 Q3 | 653.68 Thousand USD | -16.83% |
| 2011 Q4 | 643.77 Thousand USD | -1.51% |
| 2011 FY | 2.75 Million USD | -17.97% |
| 2011 Q2 | 786 Thousand USD | 16.99% |
| 2010 FY | 3.35 Million USD | 0.77% |
| 2010 Q4 | 993.56 Thousand USD | 59.11% |
| 2010 Q3 | 624.44 Thousand USD | -22.45% |
| 2010 Q2 | 805.17 Thousand USD | -14.02% |
| 2010 Q1 | 936.42 Thousand USD | 71.26% |
| 2009 Q4 | 546.79 Thousand USD | -39.01% |
| 2009 Q3 | 896.46 Thousand USD | -29.4% |
| 2009 Q2 | 1.26 Million USD | 104.37% |
| 2009 Q1 | 621.35 Thousand USD | 19.13% |
| 2009 FY | 3.33 Million USD | 25.76% |
| 2008 Q2 | 594.71 Thousand USD | -30.05% |
| 2008 Q4 | 521.57 Thousand USD | -23.81% |
| 2008 Q1 | 850.22 Thousand USD | -4.82% |
| 2008 FY | 2.65 Million USD | -52.25% |
| 2008 Q3 | 684.56 Thousand USD | 15.11% |
| 2007 FY | 5.55 Million USD | 702.2% |
| 2007 Q4 | 893.28 Thousand USD | 3.55% |
| 2007 Q3 | 862.63 Thousand USD | -40.24% |
| 2007 Q2 | 1.44 Million USD | -38.64% |
| 2007 Q1 | 2.35 Million USD | 635.86% |
| 2006 Q4 | 319.73 Thousand USD | 47.71% |
| 2006 Q1 | 60.18 Thousand USD | -82.72% |
| 2006 Q2 | 95.75 Thousand USD | 59.09% |
| 2006 FY | 692.13 Thousand USD | 9.87% |
| 2006 Q3 | 216.46 Thousand USD | 126.07% |
| 2005 Q4 | 348.39 Thousand USD | 355.22% |
| 2005 Q2 | 84.68 Thousand USD | -29.64% |
| 2005 Q1 | 120.36 Thousand USD | -6.3% |
| 2005 Q3 | 76.53 Thousand USD | -9.63% |
| 2005 FY | 629.97 Thousand USD | -10.9% |
| 2004 Q4 | 128.45 Thousand USD | -54.5% |
| 2004 Q1 | 447.4 Thousand USD | -51.08% |
| 2004 Q2 | 186.74 Thousand USD | -58.26% |
| 2004 FY | 707.07 Thousand USD | -84.11% |
| 2004 Q3 | 282.35 Thousand USD | 51.2% |
| 2003 Q3 | 799.68 Thousand USD | -16.28% |
| 2003 Q1 | 1.78 Million USD | 121.38% |
| 2003 Q2 | 955.15 Thousand USD | -46.35% |
| 2003 FY | 4.44 Million USD | 30.43% |
| 2003 Q4 | 914.55 Thousand USD | 14.36% |
| 2002 FY | 3.41 Million USD | -25.1% |
| 2002 Q4 | 804.17 Thousand USD | -17.13% |
| 2002 Q3 | 970.38 Thousand USD | 24.61% |
| 2002 Q2 | 778.73 Thousand USD | -9.26% |
| 2002 Q1 | 858.22 Thousand USD | -46.31% |
| 2001 Q2 | 1.27 Million USD | 44.71% |
| 2001 Q1 | 883.48 Thousand USD | 99.6% |
| 2001 FY | 4.55 Million USD | 929.08% |
| 2001 Q4 | 1.59 Million USD | 101.21% |
| 2001 Q3 | 794.47 Thousand USD | -37.86% |
| 2000 Q3 | 1.00 USD | 0.0% |
| 2000 Q1 | 1.00 USD | 0.0% |
| 2000 Q2 | 1.00 USD | 0.0% |
| 2000 Q4 | 442.62 Thousand USD | 44262500.0% |
| 2000 FY | 442.62 Thousand USD | 342.63% |
| 1999 FY | 100 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 194.62 Million USD | 19.684% |
| Jaguar Health, Inc. | 9.76 Million USD | -1501.414% |
| Keros Therapeutics, Inc. | 151 Thousand USD | -103419.205% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alnylam Pharmaceuticals, Inc. | 1.82 Billion USD | 91.45% |
| Ligand Pharmaceuticals Incorporated | 131.31 Million USD | -19.038% |
| ContextLogic Inc. | 287 Million USD | 45.535% |
| MiMedx Group, Inc. | 321.47 Million USD | 51.376% |
| MEI Pharma, Inc. | 65.29 Million USD | -139.389% |
| AlloVir, Inc. | - USD | -Infinity% |
| Novavax, Inc. | 983.7 Million USD | 84.11% |
| Aptorum Group Limited | 431.37 Thousand USD | -36135.969% |
| Ardelyx, Inc. | 124.45 Million USD | -25.598% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 35.068% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Vaxcyte, Inc. | - USD | -Infinity% |
| Precigen, Inc. | 6.22 Million USD | -2411.068% |
| Pharming Group N.V. | 245.31 Million USD | 36.281% |
| Phathom Pharmaceuticals, Inc. | 682 Thousand USD | -22819.941% |
| Pieris Pharmaceuticals, Inc. | 42.81 Million USD | -265.134% |
| Rigel Pharmaceuticals, Inc. | 116.88 Million USD | -33.737% |
| Avidity Biosciences, Inc. | 9.56 Million USD | -1535.084% |
| TransCode Therapeutics, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 26.97 Million USD | -479.456% |
| Sangamo Therapeutics, Inc. | 176.23 Million USD | 11.302% |
| Sol-Gel Technologies Ltd. | 1.55 Million USD | -9958.816% |
| Acelyrin, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | - USD | -Infinity% |
| Senti Biosciences, Inc. | 2.56 Million USD | -6003.631% |
| Stoke Therapeutics, Inc. | 8.78 Million USD | -1680.342% |
| AbCellera Biologics Inc. | 38.02 Million USD | -311.082% |
| Alaunos Therapeutics, Inc. | 5000.00 USD | -3126180.0% |
| BioXcel Therapeutics, Inc. | 1.38 Million USD | -11227.101% |
| Entrada Therapeutics, Inc. | 129.01 Million USD | -21.161% |
| Chimerix, Inc. | 324 Thousand USD | -48145.062% |
| VistaGen Therapeutics, Inc. | 1.06 Million USD | -14591.165% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| Corbus Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | - USD | -Infinity% |
| Alkermes plc | 1.66 Billion USD | 90.603% |
| Fortress Biotech, Inc. | 84.51 Million USD | -84.959% |
| Fortress Biotech, Inc. | 84.51 Million USD | -84.959% |
| HOOKIPA Pharma Inc. | 20.12 Million USD | -676.561% |
| Dyadic International, Inc. | 2.89 Million USD | -5292.358% |
| ImmuCell Corporation | 17.47 Million USD | -794.671% |
| Eton Pharmaceuticals, Inc. | 31.64 Million USD | -394.008% |
| IDEAYA Biosciences, Inc. | 23.38 Million USD | -568.437% |
| Lantern Pharma Inc. | - USD | -Infinity% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Incyte Corporation | 3.69 Billion USD | 95.77% |
| IO Biotech, Inc. | - USD | -Infinity% |
| Janux Therapeutics, Inc. | 8.08 Million USD | -1833.861% |
| Inhibikase Therapeutics, Inc. | 260.5 Thousand USD | -59905.374% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | 9.93 Million USD | -1473.209% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -19390.524% |
| Madrigal Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 62.83 Million USD | -148.753% |
| NextCure, Inc. | - USD | -Infinity% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -720.589% |
| Onconetix, Inc. | 58.46 Thousand USD | -267263.38% |
| Oncternal Therapeutics, Inc. | 785 Thousand USD | -19812.611% |
| Opthea Limited | 261.85 Thousand USD | -59593.957% |
| PDS Biotechnology Corporation | - USD | -Infinity% |
| PureTech Health plc | 3.33 Million USD | -4594.114% |
| Pyxis Oncology, Inc. | - USD | -Infinity% |
| Seer, Inc. | 15.18 Million USD | -929.601% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Clearside Biomedical, Inc. | 8.22 Million USD | -1800.243% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -36766.509% |
| Wave Life Sciences Ltd. | 113.3 Million USD | -37.959% |
| Xeris Biopharma Holdings, Inc. | 163.91 Million USD | 4.637% |
| C4 Therapeutics, Inc. | 20.75 Million USD | -653.103% |
| ChromaDex Corporation | 83.57 Million USD | -87.046% |
| TRACON Pharmaceuticals, Inc. | 12.04 Million USD | -1197.75% |
| Caribou Biosciences, Inc. | 34.47 Million USD | -353.386% |
| CRISPR Therapeutics AG | 371.2 Million USD | 57.89% |
| Precision BioSciences, Inc. | 48.72 Million USD | -220.795% |
| Fate Therapeutics, Inc. | 63.53 Million USD | -146.036% |
| Innoviva, Inc. | 310.46 Million USD | 49.651% |
| Summit Therapeutics Inc. | - USD | -Infinity% |
| Verrica Pharmaceuticals Inc. | 5.12 Million USD | -2950.625% |
| Aadi Bioscience, Inc. | 24.35 Million USD | -541.841% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 10 Thousand USD | -1563040.0% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 1.8 Million USD | -8584.111% |
| Catalyst Pharmaceuticals, Inc. | 398.2 Million USD | 60.745% |
| Orchestra BioMed Holdings, Inc. | 2.76 Million USD | -5563.551% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptose Biosciences Inc. | - USD | -Infinity% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 839.35 Thousand USD | -18523.021% |
| Century Therapeutics, Inc. | 2.23 Million USD | -6893.915% |
| Kura Oncology, Inc. | - USD | -Infinity% |
| TScan Therapeutics, Inc. | 21.04 Million USD | -642.62% |
| Intensity Therapeutics, Inc. | - USD | -Infinity% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 101.21 Million USD | -54.439% |
| Autolus Therapeutics plc | 1.69 Million USD | -9105.771% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 46.01 Million USD | -239.68% |
| Eterna Therapeutics Inc. | 68 Thousand USD | -229773.529% |
| Adaptive Biotechnologies Corporation | 170.27 Million USD | 8.2% |
| GRI Bio, Inc. | 21.76 Million USD | -618.124% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -6054.128% |
| Tenaya Therapeutics, Inc. | - USD | -Infinity% |
| IGM Biosciences, Inc. | 2.13 Million USD | -7238.685% |
| INmune Bio, Inc. | 155 Thousand USD | -100747.742% |
| Heron Therapeutics, Inc. | 127.04 Million USD | -23.039% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -6881.448% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | - USD | -Infinity% |
| Milestone Pharmaceuticals Inc. | 1 Million USD | -15531.4% |
| X4 Pharmaceuticals, Inc. | - USD | -Infinity% |
| Atara Biotherapeutics, Inc. | 8.57 Million USD | -1723.329% |
| Coherus BioSciences, Inc. | 257.24 Million USD | 39.235% |
| Verastem, Inc. | - USD | -Infinity% |
| Abeona Therapeutics Inc. | 3.5 Million USD | -4366.114% |
| Pliant Therapeutics, Inc. | 1.58 Million USD | -9793.291% |
| Tonix Pharmaceuticals Holding Corp. | 7.76 Million USD | -1912.281% |
| Histogen Inc. | 3.76 Million USD | -4047.36% |
| Aprea Therapeutics, Inc. | 583.23 Thousand USD | -26701.387% |
| Surrozen, Inc. | - USD | -Infinity% |
| Organovo Holdings, Inc. | 109 Thousand USD | -143307.339% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 391.69 Thousand USD | -39807.071% |
| Panbela Therapeutics, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 33.87 Million USD | -361.389% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 6.85 Million USD | -2180.957% |
| Hepion Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arcturus Therapeutics Holdings Inc. | 157.74 Million USD | 0.909% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -107111.248% |
| Apollomics, Inc. | 821 Thousand USD | -18939.464% |
| Amarin Corporation plc | 306.91 Million USD | 49.069% |
| Mesoblast Limited | 5.9 Million USD | -2548.492% |
| Turnstone Biologics Corp. | 19.3 Million USD | -709.665% |
| Kymera Therapeutics, Inc. | 78.59 Million USD | -98.893% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | - USD | -Infinity% |
| Aurinia Pharmaceuticals Inc. | 175.51 Million USD | 10.939% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.83 Billion USD | 91.459% |
| Better Therapeutics, Inc. | - USD | -Infinity% |
| Nurix Therapeutics, Inc. | 76.98 Million USD | -103.039% |
| Apellis Pharmaceuticals, Inc. | 396.59 Million USD | 60.586% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 1.33 Million USD | -11644.102% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 139.91 Million USD | -11.724% |
| Insmed Incorporated | 305.2 Million USD | 48.784% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 18.68 Million USD | -736.53% |
| OmniAb, Inc. | 34.16 Million USD | -357.54% |
| Alector, Inc. | 97.06 Million USD | -61.046% |
| Seres Therapeutics, Inc. | 126.32 Million USD | -23.74% |
| Checkpoint Therapeutics, Inc. | 103 Thousand USD | -151661.165% |
| Zai Lab Limited | 266.71 Million USD | 41.394% |
| Revance Therapeutics, Inc. | 234.04 Million USD | 33.211% |
| Aura Biosciences, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -120141.538% |
| Immunic, Inc. | - USD | -Infinity% |
| Tarsus Pharmaceuticals, Inc. | 17.44 Million USD | -795.936% |
| Veracyte, Inc. | 361.05 Million USD | 56.706% |
| InMed Pharmaceuticals Inc. | 4.59 Million USD | -3299.808% |
| FibroGen, Inc. | 147.75 Million USD | -5.795% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 147.8 Thousand USD | -105656.909% |
| Jazz Pharmaceuticals plc | 3.83 Billion USD | 95.923% |
| Cyclacel Pharmaceuticals, Inc. | 420 Thousand USD | -37117.619% |
| Amylyx Pharmaceuticals, Inc. | 380.78 Million USD | 58.95% |
| TG Therapeutics, Inc. | 233.66 Million USD | 33.103% |
| Galecto, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | - USD | -Infinity% |
| Fortrea Holdings Inc. | 3.1 Billion USD | 94.972% |
| KalVista Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptevo Therapeutics Inc. | - USD | -Infinity% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | 1.55 Million USD | -9932.991% |
| Foghorn Therapeutics Inc. | 34.15 Million USD | -357.661% |
| Y-mAbs Therapeutics, Inc. | 84.81 Million USD | -84.291% |
| Theravance Biopharma, Inc. | 57.42 Million USD | -172.21% |
| Ultragenyx Pharmaceutical Inc. | 434.24 Million USD | 64.004% |
| Metagenomi, Inc. Common Stock | 44.75 Million USD | -249.258% |
| Vaxxinity, Inc. | - USD | -Infinity% |
| BioCryst Pharmaceuticals, Inc. | 331.41 Million USD | 52.834% |
| Gain Therapeutics, Inc. | 55.18 Thousand USD | -283180.174% |
| Cartesian Therapeutics, Inc. | 26 Million USD | -501.115% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | 9000.00 USD | -1736722.222% |
| Marker Therapeutics, Inc. | 3.31 Million USD | -4620.861% |
| Regeneron Pharmaceuticals, Inc. | 13.11 Billion USD | 98.808% |
| Chemomab Therapeutics Ltd. | - USD | -Infinity% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | - USD | -Infinity% |
| Ainos, Inc. | 122.11 Thousand USD | -127908.713% |
| Pluri Inc. | 326 Thousand USD | -47849.08% |
| Prothena Corporation plc | 91.37 Million USD | -71.078% |
| Adaptimmune Therapeutics plc | 60.28 Million USD | -159.309% |
| Celularity Inc. | 22.77 Million USD | -586.461% |
| Rallybio Corporation | - USD | -Infinity% |
| Cue Biopharma, Inc. | 5.49 Million USD | -2747.25% |
| MeiraGTx Holdings plc | 14.01 Million USD | -1015.174% |
| Omeros Corporation | - USD | -Infinity% |
| Humacyte, Inc. | - USD | -Infinity% |
| Immunocore Holdings plc | 249.42 Million USD | 37.331% |
| Cocrystal Pharma, Inc. | - USD | -Infinity% |
| Cidara Therapeutics, Inc. | 63.9 Million USD | -144.604% |
| Blueprint Medicines Corporation | 249.38 Million USD | 37.319% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 30.98 Million USD | -404.418% |
| Scholar Rock Holding Corporation | - USD | -Infinity% |
| Sana Biotechnology, Inc. | - USD | -Infinity% |
| Pulmatrix, Inc. | 7.29 Million USD | -2041.874% |
| Elicio Therapeutics, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | - USD | -Infinity% |
| Intellia Therapeutics, Inc. | 36.27 Million USD | -330.914% |
| Adlai Nortye Ltd. American Depositary Shares | 4.99 Million USD | -3029.0% |
| Cytokinetics, Incorporated | 7.53 Million USD | -1975.883% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -7395.945% |
| Protara Therapeutics, Inc. | - USD | -Infinity% |
| Vor Biopharma Inc. | - USD | -Infinity% |
| Roivant Sciences Ltd. | 124.79 Million USD | -25.257% |
| Evogene Ltd. | 5.64 Million USD | -2671.525% |
| ProKidney Corp. | - USD | -Infinity% |
| Applied Therapeutics, Inc. | 9.99 Million USD | -1464.235% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 9.3 Million USD | -1580.254% |
| CorMedix Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 4.8 Million USD | -3156.542% |
| Tango Therapeutics, Inc. | 36.52 Million USD | -327.941% |
| Galectin Therapeutics Inc. | - USD | -Infinity% |
| Atai Life Sciences N.V. | 314 Thousand USD | -49681.529% |
| Renovaro Biosciences Inc. | - USD | -Infinity% |
| Aerovate Therapeutics, Inc. | - USD | -Infinity% |
| Zentalis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sagimet Biosciences Inc. | 2 Million USD | -7715.7% |
| MediciNova, Inc. | 1 Million USD | -15531.4% |
| Praxis Precision Medicines, Inc. | 2.44 Million USD | -6287.985% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -915891.796% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 270.6 Million USD | 42.234% |
| Biomea Fusion, Inc. | - USD | -Infinity% |
| PTC Therapeutics, Inc. | 937.82 Million USD | 83.332% |
| Mereo BioPharma Group plc | 10 Million USD | -1463.14% |
| Cullinan Oncology, Inc. | - USD | -Infinity% |
| Syndax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Absci Corporation | 5.71 Million USD | -2633.718% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 20.72 Million USD | -654.302% |
| Dyne Therapeutics, Inc. | - USD | -Infinity% |
| Kiniksa Pharmaceuticals, Ltd. | 270.25 Million USD | 42.161% |
| Ventyx Biosciences, Inc. | - USD | -Infinity% |
| Allakos Inc. | - USD | -Infinity% |
| Imunon, Inc. | - USD | -Infinity% |
| Fulcrum Therapeutics, Inc. | 2.8 Million USD | -5472.692% |
| Corcept Therapeutics Incorporated | 482.37 Million USD | 67.595% |
| BioAtla, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | - USD | -Infinity% |
| Allogene Therapeutics, Inc. | 95 Thousand USD | -164441.053% |
| Larimar Therapeutics, Inc. | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -3185.288% |
| Kezar Life Sciences, Inc. | 7 Million USD | -2133.057% |
| Cara Therapeutics, Inc. | 20.96 Million USD | -645.488% |
| aTyr Pharma, Inc. | 353 Thousand USD | -44181.586% |
| Aligos Therapeutics, Inc. | 15.52 Million USD | -906.594% |
| Akero Therapeutics, Inc. | - USD | -Infinity% |
| Viridian Therapeutics, Inc. | 314 Thousand USD | -49681.529% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 12.05 Thousand USD | -1296143.47% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 829.25 Million USD | 81.15% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -69001.889% |
| UroGen Pharma Ltd. | 82.71 Million USD | -88.984% |
| Sutro Biopharma, Inc. | 153.73 Million USD | -1.68% |
| ZIVO Bioscience, Inc. | 27.65 Thousand USD | -565230.922% |
| Orgenesis Inc. | 530 Thousand USD | -29393.208% |
| Entera Bio Ltd. | - USD | -Infinity% |
| GH Research PLC | - USD | -Infinity% |
| Lisata Therapeutics, Inc. | - USD | -Infinity% |
| Reneo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xencor, Inc. | 168.33 Million USD | 7.143% |
| 60 Degrees Pharmaceuticals, Inc. | 253.57 Thousand USD | -61544.576% |
| Replimune Group, Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 192.64 Million USD | 18.857% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -69001.889% |
| Portage Biotech Inc. | - USD | -Infinity% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -915891.796% |
| Olema Pharmaceuticals, Inc. | - USD | -Infinity% |
| OncoCyte Corporation | 1.5 Million USD | -10300.133% |
| Qualigen Therapeutics, Inc. | 5.2 Million USD | -2903.292% |
| Processa Pharmaceuticals, Inc. | - USD | -Infinity% |
| Purple Biotech Ltd. | - USD | -Infinity% |
| CollPlant Biotechnologies Ltd. | 10.95 Million USD | -1326.353% |
| scPharmaceuticals Inc. | 13.59 Million USD | -1049.96% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | - USD | -Infinity% |
| NeuroSense Therapeutics Ltd. | - USD | -Infinity% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | - USD | -Infinity% |
| Curis, Inc. | 10.02 Million USD | -1459.553% |
| Daré Bioscience, Inc. | 2.8 Million USD | -5466.966% |
| Carmell Therapeutics Corporation | - USD | -Infinity% |
| Titan Pharmaceuticals, Inc. | 184 Thousand USD | -84853.261% |
| Achieve Life Sciences, Inc. | - USD | -Infinity% |
| BeiGene, Ltd. | 2.45 Billion USD | 93.643% |
| Kiromic BioPharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. Warrant | 11.58 Million USD | -1249.862% |
| Protagonist Therapeutics, Inc. | 60 Million USD | -160.523% |
| Erasca, Inc. | - USD | -Infinity% |
| bluebird bio, Inc. | 29.49 Million USD | -429.932% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 2.41 Billion USD | 93.539% |
| DBV Technologies S.A. | 15.72 Million USD | -893.858% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | 6.84 Billion USD | 97.717% |
| Vincerx Pharma, Inc. | - USD | -Infinity% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -1852.461% |
| Molecular Templates, Inc. | 57.3 Million USD | -172.771% |
| Acrivon Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Travere Therapeutics, Inc. | 145.23 Million USD | -7.626% |
| Monte Rosa Therapeutics, Inc. | - USD | -Infinity% |
| Spruce Biosciences, Inc. | 10.08 Million USD | -1449.351% |
| Celldex Therapeutics, Inc. | 6.88 Million USD | -2171.016% |
| Cogent Biosciences, Inc. | - USD | -Infinity% |
| MacroGenics, Inc. | 58.74 Million USD | -166.071% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | - USD | -Infinity% |
| Aditxt, Inc. | 645.17 Thousand USD | -24128.118% |
| Adagene Inc. | 18.11 Million USD | -763.065% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -14346.765% |
| Maravai LifeSciences Holdings, Inc. | 288.94 Million USD | 45.902% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 250 Million USD | 37.476% |
| SciSparc Ltd. | 2.87 Million USD | -5329.455% |
| Vericel Corporation | 197.51 Million USD | 20.86% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 5.9 Million USD | -2547.595% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 59.6 Million USD | -162.245% |
| Invivyd, Inc. | - USD | -Infinity% |
| Relay Therapeutics, Inc. | 25.54 Million USD | -511.892% |
| Quoin Pharmaceuticals, Ltd. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 96.73 Million USD | -61.59% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 100.38 Million USD | -55.711% |
| ADMA Biologics, Inc. | 258.21 Million USD | 39.464% |
| Clene Inc. | 654 Thousand USD | -23801.223% |
| Capricor Therapeutics, Inc. | 25.17 Million USD | -520.834% |
| Boundless Bio, Inc. Common Stock | - USD | -Infinity% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 44.57 Million USD | -250.676% |
| Citius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Contineum Therapeutics, Inc. Class A Common Stock | 50 Million USD | -212.628% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 107 Thousand USD | -145987.85% |
| ALX Oncology Holdings Inc. | - USD | -Infinity% |
| Vir Biotechnology, Inc. | 86.18 Million USD | -81.381% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -213700.744% |
| Ocular Therapeutix, Inc. | 58.44 Million USD | -167.464% |
| Verve Therapeutics, Inc. | 11.75 Million USD | -1229.427% |
| Trevena, Inc. | 3.12 Million USD | -4902.048% |
| Surrozen, Inc. | - USD | -Infinity% |
| Tyra Biosciences, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 726.43 Million USD | 78.482% |
| Connect Biopharma Holdings Limited | - USD | -Infinity% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 6.28 Million USD | -2385.91% |
| Bolt Biotherapeutics, Inc. | 7.87 Million USD | -1884.688% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | - USD | -Infinity% |
| Statera Biopharma, Inc. | - USD | -Infinity% |
| ImmunityBio, Inc. | 622 Thousand USD | -25030.868% |
| Korro Bio, Inc. | - USD | -Infinity% |
| Kineta, Inc. | 5.44 Million USD | -2772.363% |
| BioVie Inc. | - USD | -Infinity% |
| Codexis, Inc. | 70.14 Million USD | -122.85% |
| Celularity Inc. | 22.77 Million USD | -586.461% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -3795.191% |
| Celcuity Inc. | - USD | -Infinity% |
| Virax Biolabs Group Limited | 156.41 Thousand USD | -99832.873% |
| Cibus, Inc. | 1.81 Million USD | -8502.862% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | - USD | -Infinity% |
| Kodiak Sciences Inc. | - USD | -Infinity% |
| Annexon, Inc. | - USD | -Infinity% |
| Adverum Biotechnologies, Inc. | 3.6 Million USD | -4242.056% |
| Assembly Biosciences, Inc. | 7.16 Million USD | -2082.242% |
| Avalo Therapeutics, Inc. | 1.92 Million USD | -8024.428% |
| Ionis Pharmaceuticals, Inc. | 787.64 Million USD | 80.154% |
| Eyenovia, Inc. | 3787.00 USD | -4127547.214% |
| Puma Biotechnology, Inc. | 235.63 Million USD | 33.663% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | - USD | -Infinity% |
| Arcellx, Inc. | 110.31 Million USD | -41.693% |
| Cardiff Oncology, Inc. | 488 Thousand USD | -31931.557% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -97.356% |
| Regulus Therapeutics Inc. | - USD | -Infinity% |
| Moolec Science SA | 905.04 Thousand USD | -17171.33% |
| Acumen Pharmaceuticals, Inc. | - USD | -Infinity% |
| Geron Corporation | 237 Thousand USD | -65855.274% |
| LAVA Therapeutics N.V. | 6.76 Million USD | -2209.263% |
| Royalty Pharma plc | 2.35 Billion USD | 93.361% |
| Atea Pharmaceuticals, Inc. | - USD | -Infinity% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 733.87 Thousand USD | -21199.929% |
| Mersana Therapeutics, Inc. | 36.85 Million USD | -324.132% |
| Humacyte, Inc. | - USD | -Infinity% |
| Structure Therapeutics Inc. | - USD | -Infinity% |
| 89bio, Inc. | - USD | -Infinity% |
| PMV Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 170 Thousand USD | -91849.412% |
| Trevi Therapeutics, Inc. | - USD | -Infinity% |
| Lexicon Pharmaceuticals, Inc. | 1.2 Million USD | -12882.89% |
| Notable Labs, Ltd. | 310 Thousand USD | -50323.871% |
| Liquidia Corporation | 17.48 Million USD | -793.836% |
| Mustang Bio, Inc. | - USD | -Infinity% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -14346.765% |
| Arbutus Biopharma Corporation | 18.14 Million USD | -761.661% |
| DiaMedica Therapeutics Inc. | - USD | -Infinity% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -8294.952% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevai Labs, Inc. Common Stock | 1.71 Million USD | -9027.318% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | - USD | -Infinity% |
| PepGen Inc. | - USD | -Infinity% |
| Moleculin Biotech, Inc. | - USD | -Infinity% |
| United Therapeutics Corporation | 2.32 Billion USD | 93.284% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 72.1 Thousand USD | -216695.651% |
| Belite Bio, Inc | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -3185.288% |
| ARS Pharmaceuticals, Inc. | 30 Thousand USD | -520946.667% |
| Bionomics Limited | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| uniQure N.V. | 15.84 Million USD | -886.644% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 64.7 Million USD | -141.587% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | - USD | -Infinity% |
| Altimmune, Inc. | 426 Thousand USD | -36593.427% |
| Amicus Therapeutics, Inc. | 399.35 Million USD | 60.858% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| Compugen Ltd. | 33.45 Million USD | -367.181% |
| Peak Bio, Inc. | 367.87 Thousand USD | -42390.833% |
| Zevra Therapeutics, Inc. | 27.46 Million USD | -469.222% |
| Benitec Biopharma Inc. | 216 Thousand USD | -72267.593% |
| Spyre Therapeutics, Inc. | 886 Thousand USD | -17542.664% |
| NKGen Biotech, Inc. Common Stock | - USD | -Infinity% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | - USD | -Infinity% |
| Aileron Therapeutics, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | - USD | -Infinity% |
| Instil Bio, Inc. | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | 87.253% |
| Immunome, Inc. | 14.01 Million USD | -1015.095% |
| Compass Therapeutics, Inc. | - USD | -Infinity% |
| Verona Pharma plc | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | - USD | -Infinity% |
| Shattuck Labs, Inc. | 1.65 Million USD | -9333.555% |
| CervoMed Inc. | 7.14 Million USD | -2087.779% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 4.91 Million USD | -3081.641% |
| Dianthus Therapeutics, Inc. | 2.82 Million USD | -5431.281% |
| Moolec Science SA | 905.04 Thousand USD | -17171.33% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 832.01 Thousand USD | -18687.515% |
| AnaptysBio, Inc. | 17.15 Million USD | -811.08% |
| Design Therapeutics, Inc. | - USD | -Infinity% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 2.46 Million USD | -6254.101% |
| Seelos Therapeutics, Inc. | 2.2 Million USD | -6995.506% |
| Lumos Pharma, Inc. | 2.05 Million USD | -7521.355% |
| Achilles Therapeutics plc | - USD | -Infinity% |
| enGene Holdings Inc. Common Stock | - USD | -Infinity% |
| 180 Life Sciences Corp. | - USD | -Infinity% |
| Opiant Pharmaceuticals, Inc. | 40.72 Million USD | -283.826% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -7395.945% |
| ORIC Pharmaceuticals, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | 204 Thousand USD | -76524.51% |
| Fractyl Health, Inc. Common Stock | 120 Thousand USD | -130161.667% |
| Rani Therapeutics Holdings, Inc. | - USD | -Infinity% |
| MoonLake Immunotherapeutics | - USD | -Infinity% |
| Palisade Bio, Inc. | 250 Thousand USD | -62425.6% |
| Tourmaline Bio, Inc. | - USD | -Infinity% |
| Beam Therapeutics Inc. | 377.7 Million USD | 58.615% |
| Neurogene Inc. | - USD | -Infinity% |
| Mirum Pharmaceuticals, Inc. | 186.37 Million USD | 16.129% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -290.785% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | - USD | -Infinity% |
| Iovance Biotherapeutics, Inc. | 1.18 Million USD | -13046.678% |
| Taysha Gene Therapies, Inc. | 15.45 Million USD | -911.676% |
| Athira Pharma, Inc. | - USD | -Infinity% |
| Vaccinex, Inc. | 570 Thousand USD | -27323.509% |
| HCW Biologics Inc. | 2.84 Million USD | -5400.539% |
| XOMA Corporation | 4.75 Million USD | -3185.288% |
| Nektar Therapeutics | 90.12 Million USD | -73.447% |
| Arvinas, Inc. | 78.5 Million USD | -99.126% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | 43.94 Million USD | -255.688% |
| Omega Therapeutics, Inc. | 3.09 Million USD | -4952.165% |
| Quince Therapeutics, Inc. | - USD | -Infinity% |
| Rezolute, Inc. | - USD | -Infinity% |
| Clene Inc. | 654 Thousand USD | -23801.223% |
| Indaptus Therapeutics, Inc. | - USD | -Infinity% |
| BeyondSpring Inc. | 1.75 Million USD | -8827.127% |
| Synlogic, Inc. | 3.37 Million USD | -4537.022% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | 367.87 Thousand USD | -42390.833% |
| Werewolf Therapeutics, Inc. | 19.94 Million USD | -683.804% |
| Krystal Biotech, Inc. | 50.69 Million USD | -208.318% |
| Karyopharm Therapeutics Inc. | 146.03 Million USD | -7.04% |
| SpringWorks Therapeutics, Inc. | 5.44 Million USD | -2769.726% |
| Lipella Pharmaceuticals Inc. | 449.61 Thousand USD | -34666.034% |
| MannKind Corporation | 198.96 Million USD | 21.435% |
| Ikena Oncology, Inc. | 9.16 Million USD | -1606.485% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 113.45 Million USD | -37.782% |
| Gossamer Bio, Inc. | - USD | -Infinity% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | - USD | -Infinity% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 285.14 Million USD | 45.18% |
| Mural Oncology plc | - USD | -Infinity% |
| Biora Therapeutics, Inc. | 4000.00 USD | -3907750.0% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | - USD | -Infinity% |
| Champions Oncology, Inc. | 50.15 Million USD | -211.662% |
| REGENXBIO Inc. | 90.24 Million USD | -73.216% |
| Ensysce Biosciences, Inc. | 2.23 Million USD | -6907.962% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | - USD | -Infinity% |
| Edgewise Therapeutics, Inc. | - USD | -Infinity% |
| Vaxart, Inc. | 7.37 Million USD | -2018.363% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | - USD | -Infinity% |
| Cellectis S.A. | 755 Thousand USD | -20603.841% |
| Longeveron Inc. | 709 Thousand USD | -21947.109% |
| Repare Therapeutics Inc. | 51.13 Million USD | -205.701% |
| Sarepta Therapeutics, Inc. | 1.24 Billion USD | 87.428% |
| Inozyme Pharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. | 11.58 Million USD | -1249.862% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | - USD | -Infinity% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 210 Thousand USD | -74335.238% |
| Vertex Pharmaceuticals Incorporated | 9.86 Billion USD | 98.416% |
| Denali Therapeutics Inc. | 330.53 Million USD | 52.708% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 16.29 Million USD | -859.161% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Passage Bio, Inc. | - USD | -Infinity% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | - USD | -Infinity% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -5682.982% |
| Scinai Immunotherapeutics Ltd. | - USD | -Infinity% |
| Rhythm Pharmaceuticals, Inc. | 77.42 Million USD | -101.883% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 152.43 Thousand USD | -102448.055% |
| Carisma Therapeutics, Inc. | 14.91 Million USD | -947.751% |
| Unicycive Therapeutics, Inc. | 675 Thousand USD | -23057.63% |
| OmniAb, Inc. | 34.16 Million USD | -357.54% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 21.25 Million USD | -635.526% |
| Lipocine Inc. | -2.85 Million USD | 5583.128% |
| Lexeo Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Nautilus Biotechnology, Inc. | - USD | -Infinity% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -6881.448% |
| G1 Therapeutics, Inc. | 82.51 Million USD | -89.446% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | 86.45 Million USD | -80.804% |
| Ocugen, Inc. | 6.03 Million USD | -2489.695% |
| Mind Medicine (MindMed) Inc. | - USD | -Infinity% |
| Q32 Bio Inc. | 1.15 Million USD | -13421.972% |
| Brainstorm Cell Therapeutics Inc. | - USD | -Infinity% |
| Alumis Inc. Common Stock | - USD | -Infinity% |
| Equillium, Inc. | 36.08 Million USD | -333.195% |
| Kyverna Therapeutics, Inc. | - USD | -Infinity% |
| Coya Therapeutics, Inc. | 6 Million USD | -2504.276% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | - USD | -Infinity% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 633.1 Thousand USD | -24590.176% |
| Dominari Holdings Inc. | 2.03 Million USD | -7566.209% |
| Edesa Biotech, Inc. | - USD | -Infinity% |
| vTv Therapeutics Inc. | - USD | -Infinity% |
| Bio-Techne Corporation | 1.15 Billion USD | 86.514% |
| Agios Pharmaceuticals, Inc. | 26.82 Million USD | -482.761% |
| Harmony Biosciences Holdings, Inc. | 582.02 Million USD | 73.143% |
| Prelude Therapeutics Incorporated | - USD | -Infinity% |
| Candel Therapeutics, Inc. | - USD | -Infinity% |
| iTeos Therapeutics, Inc. | 12.59 Million USD | -1141.08% |
| Nkarta, Inc. | - USD | -Infinity% |
| BioCardia, Inc. | 477 Thousand USD | -32670.231% |
| Iterum Therapeutics plc | - USD | -Infinity% |